|
|
|
|
pmid:
|
Serhan CN et al. |
Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability. |
1999 |
Adv. Exp. Med. Biol. |
pmid:10667343
|
Desplat V et al. |
Incorporation and effect of arachidonic acid on the growth of human myeloma cell lines. |
1999 |
Mediators Inflamm. |
pmid:10704149
|
Tornhamre S et al. |
15-Lipoxygenation of leukotriene A(4). Studies Of 12- and 15-lipoxygenase efficiency to catalyze lipoxin formation. |
2000 |
Biochim. Biophys. Acta |
pmid:10760478
|
Denizot Y et al. |
Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells. |
2000 |
Cytokine |
pmid:10857767
|
Sanak M et al. |
Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. |
2000 |
Eur. Respir. J. |
pmid:10933083
|
Serhan CN et al. |
Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity. |
2000 |
Ernst Schering Res. Found. Workshop |
pmid:10943332
|
Desplat V et al. |
Effects of lipoxygenase metabolites of arachidonic acid on the growth of human blood CD34(+) progenitors. |
2000 |
Blood Cells Mol. Dis. |
pmid:11112380
|
Kikuta Y et al. |
Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. |
2000 |
Arch. Biochem. Biophys. |
pmid:11185557
|
Serhan CN |
Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side. |
2001 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:11478391
|